​

Funding Round

Series A - Abata Therapeutics

Series A - Abata Therapeutics

Investment Firm

Overview

Abata Therapeutics is a biotech company.

Announced Date

Jun 23, 2021

Funding Type

Series A

Highlights

Location

United States, North America

Social

Investor Lead

Third Rock Ventures

Third Rock Ventures

Third Rock Ventures is a early_stage_venture and late_stage_venture and post_ipo and seed firm.

Participant Investors

5

Investor Name
Participant InvestorJDRF T1D Fund
Participant InvestorElevateBio
Participant InvestorInvus
Participant InvestorLightspeed Venture Partners
Participant InvestorThird Rock Ventures

Round Details and Background

Abata Therapeutics raised $95000000 on 2021-06-23 in Series A

Abata Therapeutics is a biotech company.

Company Funding History

1

Announcment DateTransaction NameNumber Of InvestorsLead InvestorMoney Raised
Jun 23, 2021
Series A - Abata Therapeutics
6-95.0M

Recent Activity

There is no recent news or activity for this profile.